Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBF

Recent news which mentions RHHBF

< Previous 1 2 3 4 5 Next >
Roche's Evrysdi Shows Long-Term Efficacy, Safety In Broader Spinal Muscular Atrophy Population
Tickers PTCT RHHBF RHHBY RHHVF
Tags Health Care RHHVF Benzinga
From Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
Tickers BAYRY BAYZF EXEL IPSEY
Tags RHHVF Health Care BAYZF
From Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
Tickers ANY NVS REGN RHHBF
Tags Benzinga General RHHBY
From Benzinga
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests
Tickers NVS RHHBF RHHBY RHHVF
Tags RHHVF Health Care News
From Benzinga
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
Tickers NVS RHHBF RHHBY RHHVF
Tags Benzinga General RHHBY
From Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
Tickers BIIB RHHBF RHHBY RHHVF
Tags RHHBY Biotech Diffuse Large B/Cell Lymphoma
From Benzinga
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
Tickers RHHBF RHHBY RHHVF
Tags Briefs RHHBF Market News
From Benzinga
Genentech's Evrysdi Application Under FDA Priority Review For Use In Babies Below 2 Months
Tickers RHHBF RHHBY RHHVF
Tags RHHBF RHHBY Biotech
From Benzinga
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
Tickers BIIB ESALF ESALY LLY
Tags Benzinga BIIB why it's moving
From Benzinga
Lineage, Genentech Ink Cell Therapy Licensing Pact For Ocular Diseases
Tickers LCTX RHHBF RHHBY RHHVF
Tags Benzinga Contracts General
From Benzinga
Novartis Launches New Share Buyback Program Of Up To $15B
Tickers NVS RHHBF RHHBY RHHVF
Tags Market News Movers RHHBF
From Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
Tickers AVIR RHHBF RHHBY RHHVF
Tags General Contracts Benzinga
From Benzinga
Roche's Polivy Combo Boosts Survival In Early-Stage Lymphoma Patients
Tickers RHHBF RHHBY RHHVF
Tags Diffuse Large B/Cell Lymphoma Phase 3 Trial RHHBY
From Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
Tickers RHHBF RHHBY RHHVF
Tags RHHBF Market News Briefs
From Benzinga
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
Tickers BMY INFI RHHBF RHHBY
Tags General Benzinga RHHBY
From Benzinga
Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer
Tickers RHHBF RHHBY RHHVF
Tags Biotech RHHBY Phase 2 Trial
From Benzinga
Europe Approves Roche's Tocilizumab For Patients With Severe COVID-19
Tickers RHHBF RHHBY RHHVF
Tags Briefs Market News RHHBF
From Benzinga
Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients
Tickers IMCR RHHBF RHHBY RHHVF
Tags News Trading Ideas Health Care
From Benzinga
Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests
Tickers ABT BDX CI CVS
Tags Regulations CVS CI
From Benzinga
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
Tickers ALPMF ALPMY NVS RHHBF
Tags NVS Briefs RHHBF
From Benzinga
Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer
Tickers RHHBF RHHBY RHHVF
Tags News RHHVF Health Care
From Benzinga
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
Tickers ALNY BIIB BMRN DRNA
Tags RHHBY Rumors General
From Benzinga
Spark Therapeutics' Hemophilia Gene Therapy Shows Reduction In Bleeding Episodes
Tickers RHHBF RHHBY RHHVF
Tags RHHBY Phase 2 Trial Biotech
From Benzinga
Atea Shares Plunge As Roche Culls Partnership To Develop COVID-19 Pill
Tickers AVIR RHHBF RHHBY RHHVF
Tags Small Cap Short Ideas Briefs
From Benzinga
Europe Approves Regeneron - Roche's COVID-19 Antibody Cocktail
Tickers REGN RHHBF RHHBY RHHVF
Tags Health Care RHHVF REGN
From Benzinga
EU Regulator Backs Regeneron-Roche's COVID-19 Drug
Tickers REGN RHHBF RHHBY RHHVF
Tags Biotech RHHBY FDA
From Benzinga
Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters
Tickers BIIB LLY RHHBF RHHBY
Tags Health Care LLY RHHVF
From Benzinga
ALX Oncology Falls After Updated Data For Solid Tumors Candidate
Tickers ALXO MRK RHHBF RHHBY
Tags Health Care RHHVF Trading Ideas
From Benzinga
Regeneron-Roche's COVID-19 Treatment Shows Long Term Benefit After Single Dose
Tickers REGN RHHBF RHHBY RHHVF
Tags General Benzinga RHHBY
From Benzinga
Novartis To Offload Its Stake Back To Roche For $20.7B
Tickers NVS RHHBF RHHBY RHHVF
Tags News RHHVF M&A
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.